The New England Journal of Medicine has published the results from a rigorous randomized controlled trial in Kenya. Keheala, a digital health startup, helped reduce the unsuccessful treatment outcomes for tuberculosis (TB) patients by two-thirds.
Read MoreKeheala selected by World Bank Group and Brazilian healthcare providers for piloting opportunity.
Read MoreKeheala joins global network of startups
Read MoreKeheala's innovation was recently recognized with awards from Teva Pharmaceuticals and Nefesh B'Nefesh
Read More